Multicenter prospective observational study for adjuvant chemotherapy using the eighth edition lung cancer TNM classification and clinical staging system (ILO1804)
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000043937
- Lead Sponsor
- International Lung-clinical-Research Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 962
Not provided
1) The patients had tumors where genetic testing cannot be performed for some reason (insufficient sample volume, etc. 2) Active double cancer, excluding the following curable cases even if the disease-free period is within 5 years; carcinoma in situ or mucosal cancer, prostate cancer (stage I), gastric cancer (stage 0-I), colorectal cancer (stage 0-I), esophageal cancer (stage 0), breast cancer (stage 0), thyroid cancer (papillary or follicular cancer, stage I-III), renal cancer (clear cell carcinoma or chromophobe cell cancer, stage I). 3) The patients were dead within 30 days after surgery. 4) The patients were pregnant or breastfeeding, and the patients may be pregnant, or will be pregnant, or willing to get pregnant. 5) The patients were difficult to participate in the study because of psychosis and/or mental illness. 6) The patients had grade 3 or higher adverse events 7) The attending physician judged that it was inappropriate for the patient to participate in the study. 8) The patients refused to participate in the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method